Can Lu

538 total citations
22 papers, 375 citations indexed

About

Can Lu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Can Lu has authored 22 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Can Lu's work include Cancer-related molecular mechanisms research (5 papers), Immune Cell Function and Interaction (3 papers) and Viral-associated cancers and disorders (3 papers). Can Lu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Immune Cell Function and Interaction (3 papers) and Viral-associated cancers and disorders (3 papers). Can Lu collaborates with scholars based in China, Japan and United States. Can Lu's co-authors include Chen Chen, Bin Xie, Jianhua Zhou, Tomoya Yamaguchi, Takashi Takahashi, Fang Wu, Zhenghao Deng, Jinglei Cheng, Motoshi Suzuki and Fenglei Yu and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Can Lu

22 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Lu China 12 211 103 95 58 54 22 375
Shuzhou Chu China 13 288 1.4× 92 0.9× 92 1.0× 53 0.9× 37 0.7× 19 403
Zumin Xu China 13 294 1.4× 141 1.4× 109 1.1× 47 0.8× 44 0.8× 24 427
Ailan Cheng China 12 361 1.7× 134 1.3× 128 1.3× 51 0.9× 81 1.5× 28 493
Siming Xie China 11 317 1.5× 118 1.1× 139 1.5× 55 0.9× 36 0.7× 24 519
Tinghua Hu China 12 280 1.3× 148 1.4× 138 1.5× 67 1.2× 76 1.4× 35 461
Chengjuan Jin China 13 216 1.0× 116 1.1× 79 0.8× 55 0.9× 89 1.6× 21 420
Dongyi Wan China 10 326 1.5× 146 1.4× 153 1.6× 44 0.8× 37 0.7× 16 481
Junhao Mu China 14 333 1.6× 119 1.2× 71 0.7× 67 1.2× 42 0.8× 23 442
Taisuke Hoshi Japan 6 176 0.8× 90 0.9× 75 0.8× 69 1.2× 23 0.4× 12 395

Countries citing papers authored by Can Lu

Since Specialization
Citations

This map shows the geographic impact of Can Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Lu more than expected).

Fields of papers citing papers by Can Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Lu. The network helps show where Can Lu may publish in the future.

Co-authorship network of co-authors of Can Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Lu. A scholar is included among the top collaborators of Can Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Lu. Can Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Can, et al.. (2025). Nanozyme-Based Strategies in Cancer Immunotherapy: Overcoming Resistance to Enhance Therapeutic Efficacy. Aging and Disease. 0–0. 5 indexed citations
2.
Lu, Can, et al.. (2025). Tumor organoids in cancer medicine: from model systems to natural compound screening. Pharmaceutical Biology. 63(1). 89–109. 5 indexed citations
3.
Wu, Jie, Nian Liu, Jing Chen, et al.. (2025). Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway. Journal for ImmunoTherapy of Cancer. 13(2). e010252–e010252. 5 indexed citations
4.
Lu, Can, Xiang He, Lin Wei, et al.. (2023). E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC. Cell Reports. 42(12). 113477–113477. 13 indexed citations
5.
Yang, Desong, Can Lu, Xianghuo He, et al.. (2022). Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2. Cancers. 14(22). 5688–5688. 10 indexed citations
6.
Lu, Can, Huihui Chen, Chang Wang, et al.. (2022). An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation. Frontiers in Immunology. 12. 798683–798683. 11 indexed citations
7.
Lu, Can, Xi Chen, Yuanliang Yan, et al.. (2022). Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma. Frontiers in Pharmacology. 13. 768743–768743. 8 indexed citations
8.
Lu, Can, Yuan Cai, Wei Liu, et al.. (2022). Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc. Scientific Reports. 12(1). 19168–19168. 12 indexed citations
9.
Lu, Can, et al.. (2021). Dvl2 facilitates the coordination of NF‐κB and Wnt signaling to promote colitis‐associated colorectal progression. Cancer Science. 113(2). 565–575. 14 indexed citations
10.
Jiang, He, Liyu Liu, You Zhou, et al.. (2021). Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response. Signal Transduction and Targeted Therapy. 6(1). 408–408. 10 indexed citations
11.
Lu, Can, Songshan Feng, Songming Chen, et al.. (2021). Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration. Journal of Immunology Research. 2021. 1–13. 15 indexed citations
12.
Lu, Shan, Can Lu, Yuxuan Xiao, et al.. (2020). Comparison of EML4-ALK fusion gene positive rate in different detection methods and samples of non-small cell lung cancer. Journal of Cancer. 11(6). 1525–1531. 13 indexed citations
13.
Lu, Can, Qiang Wang, Wenliang Liu, et al.. (2020). Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 46 indexed citations
14.
Xie, Bin, et al.. (2020). microRNA‐30a attenuates TGF‐β1–induced activation of pulmonary fibroblast cell by targeting FAP‐α. Journal of Cellular and Molecular Medicine. 24(6). 3745–3750. 15 indexed citations
15.
Yamaguchi, Tomoya, Masatoshi Yamamoto, Can Lu, et al.. (2019). ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma. Oncogene. 38(26). 5142–5157. 13 indexed citations
16.
Zhou, Yangying, Zhijie Xu, Wei Lin, et al.. (2019). Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. Frontiers in Oncology. 9. 683–683. 37 indexed citations
17.
18.
Zhu, Wei, Qiu‐Yan He, Can Lu, et al.. (2018). Detection of immunoglobulin and T-cell receptor gene rearrangements in angioimmunoblastic T-cell lymphoma.. PubMed. 11(5). 2642–2653. 2 indexed citations
19.
Yamaguchi, Tomoya, Can Lu, Kiyoshi Yanagisawa, et al.. (2016). ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nature Communications. 7(1). 72 indexed citations
20.
Cao, Ke, Can Lu, Shuang Han, et al.. (2015). Expression of Girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion.. PubMed. 8(1). 551–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuzhou Chu Breakdown of academic impact, for papers by Zumin Xu Breakdown of academic impact, for papers by Ailan Cheng Breakdown of academic impact, for papers by Siming Xie Breakdown of academic impact, for papers by Tinghua Hu Breakdown of academic impact, for papers by Chengjuan Jin Breakdown of academic impact, for papers by Dongyi Wan Breakdown of academic impact, for papers by Junhao Mu Breakdown of academic impact, for papers by Taisuke Hoshi
Rankless by CCL
2026